Einhorn's Greenlight Capital Raises Stake in CIT and Pfizer, Exits Boston Sci. and Adds New Xerox

David Einhorn's Greenlight Capital hedge fund issued its 13F for the quarter ended March 31, 2010. Einhorn raised his stake in CIT Group (NYSE: CIT) and Pfizer (NYSE: PFE), among others, liquidated his large Boston Scientific (NYSE: BSX) stake and added a new stake in Xerox Corp. (NYSE: XRX).

Notable Changes:

• Added 4.27 million shares of CIT Group, Inc. (NYSE: CIT) to 10.59 million shares
  
• Added 3.35 million shares of Pfizer Inc. (NYSE: PFE) to 18.15 million shares
  
• Added 1.75 million shares of EMC Corporation (NYSE: EMC) to 8.9 million shares
  
• Added 2.91 million shares of Foster Wheeler AG (Nasdaq: FWLT) to 3.63 million shares
  
• Cut 1.8 million shares of URS Corporation (NYSE: URS) to 1.8 million shares
  
• Cut 2.61 million shares of Health Management Associates Inc. (NYSE: HMA) to 6.54 million shares
  
• Liquidated 32.7 million share stake in Boston Scientific Corporation (NYSE: BSX)
  
• Liquidated 3.26 million share stake in McDermott International Inc. (NYSE: MDR)
  
• New 7 million share stake in Xerox Corp. (NYSE: XRX)
  
• New 33 million shares stake in Flagstar Bancorp Inc. (NYSE: FBC)

Market Moving News and Intelligence - Free Trial
http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• Scorpion Capital says short Twist Biosciences